The Use of Machine Learning Methods in Neurodegenerative Disease Research: A Scoping Review

Antonio Ciampi, Julie Rouette, Fabio Pellegrini, Gabrielle Simoneau, Bastien Caba, Arie Gafson, Carl de Moor, Shibeshih Belachew
doi: https://doi.org/10.1101/2023.07.31.23293414

Article Information

doi 
https://doi.org/10.1101/2023.07.31.23293414
History 
  • July 31, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Antonio Ciampi1,
  2. Julie Rouette1,2,
  3. Fabio Pellegrini3,*,
  4. Gabrielle Simoneau4,
  5. Bastien Caba4,
  6. Arie Gafson5,
  7. Carl de Moor6 and
  8. Shibeshih Belachew5
  1. 1From the Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
  2. 2Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
  3. 3Biogen Digital Health, Madrid, Spain
  4. 4Biogen Digital Health, Mississauga, Ontario, Canada
  5. 5Biogen Digital Health (A.G., S.B.), Zug, Baar, Switzerland
  6. 6Biogen Digital Health, Cambridge, MA
  1. ↵*Correspondence: Fabio Pellegrini, Neuhofstrasse 30 - 6340 Baar, Switzerland; phone, +41 41 882 07 61; fax: +41 41 392 17 10; mobile, +41 79 505 39 66; e-mail, fabio.pellegrini{at}biogen.com
Back to top
Posted July 31, 2023.
Download PDF

Supplementary Material

Data/Code
Email
The Use of Machine Learning Methods in Neurodegenerative Disease Research: A Scoping Review
Antonio Ciampi, Julie Rouette, Fabio Pellegrini, Gabrielle Simoneau, Bastien Caba, Arie Gafson, Carl de Moor, Shibeshih Belachew
medRxiv 2023.07.31.23293414; doi: https://doi.org/10.1101/2023.07.31.23293414
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area